Daou Farah, Cochis Andrea, Leigheb Massimiliano, Rimondini Lia
Department of Health Sciences, Center for Translational Research on Autoimmune and Allergic Diseases-CAAD, Università del Piemonte Orientale UPO, 28100 Novara, Italy.
Department of Orthopaedics and Traumatology, "Maggiore della Carità" Hospital, 28100 Novara, Italy.
Materials (Basel). 2021 Dec 21;15(1):31. doi: 10.3390/ma15010031.
Functional ability is the basis of healthy aging. Articular cartilage degeneration is amongst the most prevalent degenerative conditions that cause adverse impacts on the quality of life; moreover, it represents a key predisposing factor to osteoarthritis (OA). Both the poor capacity of articular cartilage for self-repair and the unsatisfactory outcomes of available clinical interventions make innovative tissue engineering a promising therapeutic strategy for articular cartilage repair. Significant progress was made in this field; however, a marked heterogeneity in the applied biomaterials, biofabrication, and assessments is nowadays evident by the huge number of research studies published to date. Accordingly, this literature review assimilates the most recent advances in cell-based and cell-free tissue engineering of articular cartilage and also focuses on the assessments performed via various in vitro studies, ex vivo models, preclinical in vivo animal models, and clinical studies in order to provide a broad overview of the latest findings and clinical translation in the context of degenerated articular cartilage and OA.
功能能力是健康老龄化的基础。关节软骨退变是最常见的退行性疾病之一,会对生活质量产生不利影响;此外,它是骨关节炎(OA)的一个关键诱发因素。关节软骨自我修复能力差以及现有临床干预效果不理想,使得创新组织工程成为关节软骨修复的一种有前景的治疗策略。该领域取得了重大进展;然而,从迄今为止发表的大量研究来看,目前在应用的生物材料、生物制造和评估方面存在明显的异质性。因此,这篇文献综述总结了基于细胞和无细胞的关节软骨组织工程的最新进展,并着重介绍了通过各种体外研究、离体模型、临床前体内动物模型和临床研究进行的评估,以便在退变的关节软骨和OA背景下对最新研究结果和临床转化进行全面概述。